Ofev® (nintedanib)
| Full Name | Ofev® (nintedanib) |
| Drug | Ofev |
| Manufacturer | Boehringer Ingelheim |
| Route of Administration | Oral |
| Site of Care | Home |
| Approved Indication | Treatment of idiopathic pulmonary fibrosis (IPF) in adults, treatment of chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype in adults, or slowing the rate of decline in pulmonary function in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD) |
| Disease | Idiopathic Pulmonary Fibrosis (IPF); Systemic Sclerosis Interstitial Lung Disease (SSc-ILD) |
| Therapeutic Area | Pulmonology |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 800-373-1452 |
| Fax Number | 888-975-1456 |
| Product Website | ofev.com |
| Patient Resources | Pulmonary Fibrosis Foundation |